• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II EXTENSION STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II EXTENSION STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Model Number ETCF3636C49EJ
Device Problems Burst Container or Vessel (1074); Leak/Splash (1354); Device Damaged by Another Device (2915)
Patient Problems Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/04/2021
Event Type  Injury  
Event Description
An endurant iis bifurcated stent graft was implanted during an endovascular procedure for the treatment of a ruptured abdominal aortic aneurysm.Non mdt limbs were implanted on both sides.External iliac artery (eia) landing was performed on the right internal iliac artery (iia) plug.During the index procedure, after final angiography a leak was found so an endurant aortic extension was implanted.At the time of touch up, a unknown balloon interfered with a suprarenal stent and burst.So even though the balloon was raised from the right contralateral side, it got caught in the suprarenal stent and was difficult to be retrieved.The balloon was retrieved somehow, but the type ia endoleak was still remaining.Performing a chevar procedure was considered but the physician judged that additional treatment would be difficult due to the morphology of the suprarenal stent.Since it was not possible to place the patient under observation since it was a rupture case, the physician opted for an open y graft replacement and explanted the bifurcated stent graft and the cuff.  as per the physician the cause of the event was due to the patients vessel morphology and stated evar treatment was difficult.No additional clinical sequalae was provided and the patient is fine.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
B5;additional information received : it was confirmed that 3 reliant balloons were used in the procedure and ruptured.In the two of them, the shape of the centre was poor, and there was a part where the suprarenal stent floated.It seemed that the inflated balloon came into contact with suprarenal stents and ruptured.The other balloon passed through the inside of the suprarenal stent which was lifted from the contralateral side with the guidewire floating, and then was stuck and ruptured while the balloon was being retrieved.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II EXTENSION STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key12967359
MDR Text Key281976105
Report Number9612164-2021-04782
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/23/2023
Device Model NumberETCF3636C49EJ
Device Catalogue NumberETCF3636C49EJ
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/19/2021
Date Device Manufactured06/26/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age88 YR
Patient SexFemale
-
-